Cerebral Folate Deficiency (Syndrome), Folate Receptor Autoantibodies and ASD: An Overview

If you are reading this, you are likely searching for answers to help your child. You may have heard about “cerebral folate deficiency” (CFD) or “folate receptor autoantibodies” (FRAAs) in online parent groups, autism conferences, in the news, or from your child’s doctor. This information can certainly feel overwhelming and confusing.

There are many moving parts to the science behind cerebral folate deficiency and folate receptor autoantibodies and how this relates to neurodevelopmental disorders such as autism. Let’s break it down so that it may be clearer to understand; how this relates to autism, what testing and treatment involve, and most importantly — what you need to know to make informed decisions for your child. The goal is to give you clear, honest, and practical information based on current medical research, while acknowledging what we know and what we still do not know.

Folate: The Brain’s Essential Fuel

Folate (also called vitamin B9) is a nutrient that every cell in your child’s body needs. But the brain has an especially high demand for folate — far higher than any other organ.

Think of folate as the fuel that powers brain development and function. It helps with:

• Building brain cells — especially during the first years of life when the brain grows rapidly
• Creating connections between brain cells (synapses) that allow learning and memory
• Making neurotransmitters — the chemical messengers like serotonin and dopamine that regulate mood, attention, and behavior
• Repairing and maintaining brain cells throughout life
• Myelination — wrapping nerve fibers with insulation so signals travel quickly (like coating electrical wires)

When the brain does not get enough folate, it cannot function properly. This can lead to developmental delays, regression (losing skills), seizures, movement problems, and — in some cases — features that look like autism.

Folate Receptor Alpha – A Critical Gateway

Here is something many parents do not realize: Having normal folate levels in the blood does NOT mean the brain has enough folate.

The brain is protected by something called the blood-brain barrier — a security system that keeps harmful substances out but also makes it difficult for good things (like folate) to get in. To solve this problem, the body uses a special “delivery channel” called the folate receptor alpha (FRα) .

This receptor sits on the surface of cells that form the barrier between blood and brain (the choroid plexus). It grabs folate from the blood and transports it into the cerebrospinal fluid (CSF) — the clear liquid that bathes the brain and spinal cord. From there, the folate spreads throughout the brain.

Key point for parents: Blood tests for folate only tell you what is in the bloodstream — NOT what has reached the brain. A child can have perfectly normal blood folate levels but still have a brain starving for folate. This is the central puzzle of cerebral folate deficiency.

The Definition

Cerebral folate deficiency (CFD) means there is too little folate in the brain, specifically in the cerebrospinal fluid (CSF), despite normal or even high levels in the blood.

The name “cerebral” means “related to the brain.” So CFD literally means “brain folate deficiency.”

This is not the same as having low folate in your diet (nutritional folate deficiency). A child with CFD can eat plenty of folate-rich foods and take supplements — but their brain still cannot get enough because the delivery system is broken.

How Is CFD Diagnosed?

The only way to definitively diagnose CFD is to measure folate levels in the cerebrospinal fluid. This requires a lumbar puncture (also called a spinal tap) — a procedure where a needle is inserted into the lower back to collect a small sample of fluid.

Normal CSF folate levels (5-MTHF) for children: Generally, above 40-70 nmol/L (the exact number depends on age and the specific lab)

CFD is diagnosed when: CSF folate is below 40-50 nmol/L AND blood folate is normal
Many parents are understandably concerned about lumbar puncture. It is an invasive procedure performed under local anesthesia (sometimes with sedation for children). While generally safe, it carries small risks including headache, bleeding, or infection. For this reason, doctors do not recommend lumbar puncture for every child with autism — only those with strong clinical suspicion of CFD.

Cerebral Folate Deficiency (CFD) is considered a rare disorder?

Technically, yes, it is. And this is where some of the confusion starts. Here is a breakdown of what that means for you and your child.

The Official Definition of ‘Rare’
In the medical world, a disease is classified as “rare” if it affects a small number of people. For CFD Syndrome specifically, the official statistics are as follows:

• Prevalence: Less than 1 in 1,000,000 people.
• Reported Cases: Only fewer than ~50 individuals with the genetic form of the condition have been described in the entire scientific literature.

To put this in perspective, this makes CFD significantly rarer than most other well-known neurological conditions.

Why This Is Confusing: A Crucial Distinction

You might be wondering: If this is so rare, why have I heard so much about it, especially in relation to autism?

This is the most important part to understand. The term “Cerebral Folate Deficiency” is used to describe two different, but related, medical situations:

1. CFD Syndrome (The Ultra-Rare Genetic Disease)
   • Cause: A genetic mutation (specifically in the FOLR1 gene) that is passed down through families.
   • Inheritance: Autosomal recessive (both parents must carry the gene).
   • Rarity: Extremely rare (the statistics above apply to this form). It is a severe, progressive neurodegenerative disorder if untreated.
2. CFD Secondary to Autoantibodies (The More Common Condition)
   • Cause: The immune system produces Folate Receptor Autoantibodies (FRAAs) that block the receptor, preventing folate from reaching the brain. There is no genetic mutation.
   • Inheritance: Not inherited in a classic genetic pattern.
   • Rarity: This is significantly more common. As noted in the previous report, studies suggest that over 70% of children with autism may test positive for these autoantibodies, though not all will have full-blown CFD.

How to Think About This as a Parent

When you hear a doctor say “Cerebral Folate Deficiency is a rare disorder,” they are usually referring to the genetic, inherited form.

However, the autoimmune form (blocking antibodies) is much more prevalent and is the one that parents of children with autism are likely investigating.

Think of it this way:

• Genetic CFD: A broken “delivery truck” (the receptor) due to a manufacturing defect. Very rare.
• Autoimmune CFD: A “roadblock” (the autoantibody) stopping the delivery truck. Much more common, especially in neurodevelopmental disorders.

What Causes CFD?

There are several possible causes, but the most common cause — especially in children with autism — involves the immune system.

For most children with autism who have CFD, the cause may be folate receptor autoantibodies — which we will explain next.

What Are Autoantibodies?

To understand FRAAs, you first need to understand antibodies. Antibodies are proteins your immune system makes to fight off invaders like viruses and bacteria. They are like “wanted posters” that help your immune system find and destroy harmful things.

Autoantibodies are antibodies that mistakenly target your own body instead of invaders. “Auto” means self. So, autoantibodies are friendly fire — the immune system attacking healthy parts of the child’s own body.

Folate Receptor Autoantibodies (FRAAs)

Folate receptor autoantibodies are autoantibodies that attack the folate receptor (FRα) — the “delivery channel” that transports folate from blood into the brain.

There are two main types:

Both types result in the same problem: less folate gets into the brain.

How Do Children Develop FRAAs?

Researchers are still studying this, but several theories exist:

Theory 1 — Dairy proteins: Some research suggests that certain proteins in cow’s milk (and possibly other dairy products) look similar to the human folate receptor. The immune system may make antibodies against dairy proteins, and those antibodies “cross-react” and also attack the folate receptor. This is called molecular mimicry.

Theory 2 — Genetic susceptibility: Some children may have genes that make them more likely to develop autoantibodies. FRAAs tend to run in families — if one child has them, siblings or parents may also have them even without symptoms.

Theory 3 — Environmental triggers: Viral infections, gut inflammation, or other environmental factors might trigger the immune system to start attacking the folate receptor.

How Common Are FRAAs?

This depends on the population:

Important: A 71% prevalence means about 7 out of 10 children with autism test positive for FRAAs. However, testing positive does NOT automatically mean your child has CFD — because having autoantibodies does not always mean they are causing significant brain folate deficiency. The correlation is strong but not perfect.

The Numbers

Multiple studies have found a strong association between FRAAs, CFD, and autism:

• 38% of children with ASD have confirmed CFD (based on lumbar puncture studies)
• 71% of children with ASD test positive for FRAAs (based on blood tests)
• 83% of CFD cases in children with ASD are caused by FRAAs

This means that a significant subset of children with autism — perhaps one-third to two-thirds — have detectable FRAAs, and many of those have measurable brain folate deficiency.

Which Children with Autism Are Most Likely to Have CFD?

Not every child with autism has CFD. The research suggests certain “red flags” make CFD more likely:
Strongly suggestive features:

• Developmental regression — losing skills (language, social, motor) that were previously acquired, especially between 4-18 months of age
• Movement problems — low muscle tone (hypotonia), clumsiness, unsteady walking (ataxia), or unusual movements (chorea, dystonia)
• Seizures or epilepsy — especially if difficult to control with medication
• Acquired microcephaly — head growth slows down or stops, falling off the growth curve
• Sleep disturbances — severe or persistent insomnia, night waking
• Irritability — unexplained, inconsolable crying or agitation in younger children

Less specific but common features:

• Language impairment (more severe than typical autism)
• Motor apraxia (difficulty planning and coordinating movements)
• Stereotypies (repetitive movements)
• Poor response to standard autism interventions

Key point: A child with autism who has regression plus movement abnormalities (especially low muscle tone or ataxia) is much more likely to have CFD than a child with autism alone.

What Does This Mean for Your Child?

If your child has autism and some of these “red flags,” CFD might be contributing to their symptoms. This is important because CFD is treatable. Treating CFD may not “cure” autism, but it may significantly improve certain symptoms — especially movement, seizures, language, and irritability.

Even if your child does not have classic red flags, they could still have FRAAs or mild CFD. The research is ongoing, and we do not yet have clear guidelines on who should be tested.

CFD can cause a wide range of symptoms that often overlap with autism, making it hard to distinguish. However, some symptoms are more specific to CFD.

Core Neurologic Symptoms of CFD

Symptoms That Overlap with Autism

• Social withdrawal or disinterest
• Language delays or loss of speech
• Repetitive behaviors (stereotypies)
• Irritability and agitation
• Sleep disturbances
• Poor eye contact

Age of Onset

Most children with CFD due to FRAAs develop normally for the first 4-6 months of life. Parents often describe a baby who was meeting milestones, smiling, cooing, and reaching for objects — and then things changed.
Between 4 and 18 months (usually around 6-12 months), parents notice:

• Loss of skills (stops babbling, stops reaching, loses social smile)
• Increasing irritability and inconsolable crying
• Sleep problems
• Loss of muscle tone (baby feels floppy)
• Seizures may begin

This pattern — normal development followed by regression with movement problems — is highly suggestive of CFD.

Important for parents of older children: CFD can also present later in childhood or even in adulthood, but this is less common.

The Two Types of Tests

There are two main tests relevant to CFD:

The FRAT^® Test —
This is critical for parents to understand. FRAT^® is a CLIA certified test that measures the presence of both blocking and binding folate receptor autoantibodies. It will distinguish between the two types of autoantibodies (sometimes both are present) and quantify the titer levels of the autoantibodies. FRAT^® may only be prescribed by a physician; therefore, you will need to work with your physician to order the test. This is optimal as you can work directly with your physician to develop a specific treatment plan.

Every child with autism is unique. What works for one child may not work for another.

A FRAT^® collection kit may be ordered here:
https://www.fratnow.com/order-a-test-kit.php

What Is Folinic Acid?

Folinic acid (also called leucovorin) is a medication that is a reduced, active form of folate. It is different from folic acid (the synthetic form found in supplements and fortified foods). IT IS NOT FDA APPROVED FOR AUTISM.

Why has folinic acid been used off-label? Because it can enter brain cells through alternative routes — it does NOT need the folate receptor (FRα) that is blocked by autoantibodies. It uses other transporters (RFC and PCFT) to get into the brain, bypassing the blocked receptor.

Important: Folinic acid is NOT the same as folic acid. In fact, folic acid can make CFD worse by competing for the already damaged receptor. Parents are advised to avoid folic acid supplements and folic acid-fortified foods in children with suspected CFD.

How Is It Given?

• Form: Oral tablets (5 mg, 10 mg, 15 mg, 25 mg) that can be crushed or split
• Dose: Typically 0.5 to 2 mg per kilogram of body weight per day, divided into two doses
• Example: A 20 kg (44 lb) child might take 10-20 mg twice daily
• Duration: At least 4-6 months to see full effect; many children take it for years
• Taste: Tablets can be bitter; many parents mix with applesauce, pudding, or juice

Does It Work? The Evidence

For confirmed CFD (by lumbar puncture):

• 70-100% of children show improvement when treated early (before age 6)
• Best results with early intervention — the longer the brain goes without folate, the less reversible the damage

For children with autism and FRAAs (with or without confirmed CFD):

Research studies (including randomized controlled trials) show:

What parents report: Many parents describe their child becoming more “present,” making better eye contact, using more words or gestures, sleeping better, and being less irritable. Some children who were completely nonverbal start saying words or using augmentative communication devices more effectively.

What parents should know: Not every child responds. Some studies show no benefit over placebo. The quality of evidence is limited by small study sizes and lack of large, multicenter trials. However, the safety profile is good, which makes many doctors consider it’s use after a positive FRAT^® test.

Side Effects and Risks

Folinic acid is generally safe, but side effects can occur:
Common side effects (occur in 5-15% of children):

• Increased agitation or hyperactivity (paradoxical reaction)
• Aggression or irritability (worse before it gets better)
• Insomnia (trouble sleeping)
• Headache
• Nausea, stomach upset, diarrhea
• Appetite changes (increased or decreased)

Serious but rare:

• Allergic reaction (rash, difficulty breathing — seek immediate help)
• Masking of vitamin B12 deficiency (the most important risk)

Medication alone is often not enough. Addressing underlying factors may enhance improvement.

Consider a Dairy Elimination Trial

If your child has FRAAs (or even if they do not, but CFD is suspected), a trial off cow’s dairy may help.

Rationale: Dairy proteins (especially from cow’s milk) may trigger the production of FRAAs through molecular mimicry. Removing the trigger may allow the immune system to stop producing autoantibodies.

How to do it:

• Eliminate ALL cow dairy: milk, cheese, yogurt, butter, cream, whey, casein
• Ghee (clarified butter) may be tolerated as milk solids are removed
• Trial duration: Minimum 4-6 weeks (some children need 3-6 months)
• Keep a symptom diary before and during the trial

What to expect: Some parents report dramatic improvements in behavior, language, and sleep after removing dairy. Others see no change. A subset of children may need to remain dairy-free long-term.

How to Bring This Up

Many doctors are unfamiliar with CFD and FRAAs and the FRAT^® test. Here is a script you can use:

“I’ve been reading about cerebral folate deficiency and folate receptor autoantibodies in autism. My child has [list red flags: regression, low muscle tone, seizures, etc.]. Could we discuss whether this might be relevant and whether testing for folate receptor autoantibodies and leucovorin makes sense?”

What to Expect

Some doctors may be:

• Open and curious — willing to learn and explore
• RSkeptical — concerned about lack of large studies, unstandardized testing, or off-label use
• Dismissive — may tell you it is “pseudoscience” or “not real”

If your doctor is dismissive, consider:

• Asking for a second opinion from a specialist (child neurologist, metabolic geneticist, or developmental pediatrician with interest in autism biomarkers)
• Bringing printed copies of peer-reviewed studies (available on PubMed), or on https://www.fratnow.com/publication.php
• Seeking a referral to a university medical center with experience in CFD

What FRAT^® testing and Folinic Acid Can and Cannot Do

Can:

• Improve language and communication
• Reduce irritability and improve mood
• Improve sleep
• Reduce or eliminate seizures
• Improve motor function (balance, coordination, muscle tone)
• Increase alertness and social engagement

Cannot:

• Cure autism
• Reverse all brain damage if treatment is started late
• Work for every child (some do not respond)
• Replace behavioral, educational, and speech therapies

Think of it this way: FRAT^® testing Folinic acid is not a magic bullet. They are tools that may remove a biological barrier, allowing your child to benefit more from other interventions (speech therapy, occupational therapy, behavioral therapy). For some children, the difference is dramatic. For others, it is subtle. For some, none at all.

Hope Is Not Denial
Seeking treatment for CFD does not mean you are in denial about your child’s autism. It means you are a proactive parent exploring all possible contributing factors. Many children have both autism AND CFD. Treating CFD does not mean you think autism is “just a deficiency” — it means you understand that biology is complex and multiple factors can coexist.

The journey is hard. You have likely tried diets, supplements, therapies, and more. You have probably been told “there’s nothing wrong with his blood work” or “she’s just autistic” when you knew something deeper was happening.

Trust your instincts. If your child lost skills, if they are struggling with movement or seizures, if they seem “stuck” despite your best efforts — CFD is worth exploring.

Not every child will have it. Not every child who has it will respond to treatment. But for those who do, the difference can be life-changing.

You are your child’s best advocate. Now you have the information to have an informed conversation with your doctor. Whether you pursue testing, treatment, or simply watch and wait — you are making an informed choice.

You are not alone. Thousands of parents are asking these same questions. And researchers are working hard to get better answers.

Scientific Articles (for sharing with doctors)

1. Rossignol DA, Frye RE. Cerebral folate deficiency, folate receptor alpha autoantibodies and leucovorin treatment in autism spectrum disorders: A systematic review and meta-analysis. J Pers Med. 2021;11(11):1141.
2. Ramaekers VT, et al. Folate receptor autoantibodies and cerebral folate deficiency in autism. Mol Psychiatry. 2013;18(3):369-81.
3. Frye RE, et al. Folate receptor alpha autoantibodies in autism spectrum disorders: Diagnosis, treatment and prevention. J Pers Med. 2021;11(8):710.

You have made it to the end of a long and detailed guide. That alone speaks to your dedication as a parent.

Cerebral folate deficiency and folate receptor autoantibodies represent a real, measurable, and treatable biological condition that affects a significant subset of children with autism. The science is still evolving, the tests are imperfect, and the treatments are not magic — but for many families, exploring this path has led to meaningful improvements.

Talk to your doctor. Ask questions. Trust your instincts. And above all, continue to love and support your child exactly as they are — while never stopping your search for ways to help them thrive.

You are your child’s best hope. And now you are better informed than ever before.

• Ramaekers, V.T., et al. (2005). Autoantibodies to Folate Receptors in the Cerebral Folate Deficiency Syndrome. New England Journal of Medicine.
• Frye, R.E., et al. (2012). Cerebral folate receptor autoantibodies in autism spectrum disorder. Molecular Psychiatry.
• Frye, R.E., & Rossignol, D.A. (2020). Cerebral Folate Deficiency in Autism Spectrum Disorder.
• Zheng, Y., & Cantley, L.C. (2019). Toward a better understanding of folate metabolism in health and disease. Journal of Experimental Medicine.
• Frye, R.E., & Slattery, J. (2024). Precision diagnosis and treatment of vitamin metabolism-related epilepsy.
• https://www.uclahealth.org/medical-services/clinical-genetics/folinic-acid-cerebral-folate-deficiency-and-autism-faq
• Rossignol DA, Frye RE. Cerebral folate deficiency, folate receptor alpha autoantibodies and leucovorin treatment in autism spectrum disorders: A systematic review and meta-analysis. J Pers Med. 2021;11(11):1141.
• Ramaekers VT, et al. Folate receptor autoantibodies and cerebral folate deficiency in autism. Mol Psychiatry. 2013;18(3):369-81.
• Frye RE, et al. Folate receptor alpha autoantibodies in autism spectrum disorders: Diagnosis, treatment and prevention. J Pers Med. 2021;11(8):710